Breaking News

Celyad Oncology SA (CYADY)

OTC Markets

Add to/Remove from a Portfolio Add to Watchlist

Celyad Oncology historical data, for real-time data please try another search

0.600 0.000 0.00%

25/10 - Closed. Currency in USD

Type: Equity

Market: United States

Volume: 0
Bid/Ask: 0.000 / 0.000
Day's Range: 0.401 - 0.645

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
Forum

Celyad Oncology SA Company Profile

Get an in-depth profile of Celyad Oncology SA, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

Equity Type

ORD

Celyad Oncology SA, a biotechnology company, focuses on the research and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. It operates through Immuno-Oncology and Cardiology segments. The company develops short hairpin ribonucleic acid (shRNA) non-gene-edited technology, which allows for the development of allogenic CAR T-cells through the modulation of genes encoding the T-cell receptor (TCR) without the need for gene editing; NKG2D-based CAR T-cells and multi-specific CAR T-cell platform; and B7-H6 targeting CAR T-cells. It also engages in the development of CYAD-01, a CAR T-cell product candidate based on the natural killer group 2D (NKG2D); CYAD-02, an autologous NKG2D-based CAR T-cell candidate used to target the NKG2D ligands (NKG2DL) MICA/B to prevent cell fratricide and improve cell persistence; and CYAD-211, an allogeneic B-cell maturation antigen (BCMA)-targeting CAR T-cell candidate. In addition, the company offers C-Cathez, an intra-myocardial injection catheter. It has a license agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; research and development collaboration, and license agreements with Hr for the use of shRNA to downregulate such targets in immune cells and the combination of shRNAs with a chimeric antigen receptor in immune cells; and a license agreement with Mesoblast to develop and commercialize C-Cathez. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

Contact Information

Address Axis Business Park Rue André Dumont 9
Mont-Saint-Guibert, 1435
Belgium

Phone 32 1 039 41 00

Fax 32 1 039 41 41

Web celyad.com

Top Executives

Name	Age	Since	Title
Andrea Gothing	-	2024	Non-Executive Director
John Campbell	-	-	Member of Scientific Advisory Board
Jonathan James	-	2024	Non-Executive Director
Sage Mandel	-	2024	Non-Executive Director
Gerry Graham	-	-	Member of Scientific Advisory Board
Hinrich Abken	-	2016	Member of Scientific Advisory Board
Christopher LiPuma	-	2022	Non-Executive Director
Marina Udier Blagovic	-	2020	Independent Director
Michel E. J. Lussier	68	2007	Co-Founder & Non-Executive Director
Marco L. Davila	-	2016	Member of Scientific Advisory Board
Jean-Christophe Marine	-	-	Member of Scientific Advisory Board
Ami Patel Shah	-	2021	Non-Executive Director
Ann Ager	-	-	Member of Scientific Advisory Board
Matthew R. Kane	47	2024	CEO & Executive Director
Serge Goblet	67	2008	Non-Executive Director
Dominic G. Piscitelli	50	2020	Independent Director
Hilde Windels	60	2017	Independent Chairwoman of the Board
Margo R. Roberts	70	2018	Member of Scientific Advisory Board

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

CYADY Comments

Write your thoughts about Celyad Oncology SA

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	5,138.16	-1.77	-0.03%
NSE All Share	141,023.38	+19.23	+0.01%
US 30	45,534.5	-97.2	-0.21%
US 500	6,451.4	-15.5	-0.24%
FTSE 100	9,321.40	+12.20	+0.13%
DAX	24,288.03	-82.71	-0.34%
South Africa Top 40	95,432.40	+365.54	+0.38%

Brent Oil	67.39	+0.17	+0.25%
Crude Oil WTI	63.88	+0.22	+0.35%
Gold	3,410.70	-7.80	-0.23%
Silver	38.688	-0.367	-0.94%
Copper	4.5350	+0.0075	+0.17%
London Cocoa	5,332.00	-26.00	-0.49%
London Wheat	168.05	-1.25	-0.74%

Nigeria 10Y	15.681	0.00	0.00%
Nigeria 2Y	16.836	+0.000	+0.00%
U.K. 10Y	4.6900	-0.0380	-0.80%
Germany 10Y	2.7575	+0.0385	+1.42%
U.S. 10Y	4.275	+0.015	+0.35%
U.S. 5Y	3.775	+0.018	+0.48%
U.S. 2Y	3.713	+0.025	+0.68%

Fidelitybk	21.000	+0.100	+0.48%
Zenith Bank	69.55	-0.45	-0.64%
UBA	48.10	+0.15	+0.31%
First HoldCo	32.30	-0.20	-0.62%
Guaranty Trust Holding	95.00	+1.00	+1.06%
Sterling Bank	7.900	+0.350	+4.64%
Dangote Cement	518.00	-2.00	-0.38%

Recent Quotes

Name	Price	Chg.	Chg. %
CYADY	0.600	0.000	0.00%
BEZ/BTC	0.00000009	0.00000000	0%
EQD	10.020	+0.000	+0.00%
Invesco S&P Europ.	26.88	+0.26	+0.98%
AB SICAV I - Low .	26.690	+0.240	+0.91%
BCDN/USD	0.000188	+0.000005	+2.74%
SHMD	2.53	-0.11	-4.17%
RS_pa	10.21	0.00	0.00%

Market Movers

Name	Last	Chg. %	Vol.
Sovereign Trust Insurance Plc	2.71	+2.26%	15.94M
UBA	48.10	+0.31%	2.79M
First HoldCo	32.30	-0.62%	1.45M
Zenith Bank	69.55	-0.64%	538.53K
Nascon	89.70	-0.33%	312.18K
MTN Nigeria	415.00	-4.60%	119.24K
Aradel Holdings	515.00	-0.77%	118.94K

Name	Last	Chg. %	Vol.
SCOA Nigeria	6.050	+10.00%	13.00K
McNichols	3.52	+10.00%	29.30K
Cutix	3.900	+9.86%	240.21K
Nem	29.200	+9.77%	44.73K
Thomaswy	3.29	+9.67%	76.96K
Coronation Insurance	3.50	+9.03%	1.07M
Universal Insurance PLC	1.33	+9.02%	14.28M

Name	Last	Chg. %	Vol.
Geregu Power	1,027.40	-10.00%	5.04K
Okomu Oil Palm	918.00	-10.00%	13.24K
Transcorp Power	257.90	-9.98%	6.44K
Eternaoil	34.25	-9.87%	4.34K
UAC Of Nigeria	72.10	-9.82%	42.07K
BUA Cement	138.50	-8.76%	59.99K
Presco	1,380.00	-6.76%	16.49K